Analysis of mutations in primary and metastatic synovial sarcoma
暂无分享,去创建一个
C. Morrison | Jianmin Wang | Song Liu | W. Bshara | Christopher Choi | J. Conroy | S. Glenn | Lei Wei | A. Pao | Tao Yu | Y. E. Yu | Zhuo Xing | A. Kawai | S. Tanaka | Xiaoling Jiang | Wiam | Bshara
[1] S. Linnarsson,et al. Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs) , 2018, BMC Cancer.
[2] R. C. Poulos,et al. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription. , 2017, Cancer research.
[3] Soo Hyun Lee,et al. ARID1B alterations identify aggressive tumors in neuroblastoma , 2017, Oncotarget.
[4] T. Olencki,et al. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors , 2017, Cancer.
[5] H. Groen,et al. Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors , 2016, Carcinogenesis.
[6] K. Jang,et al. CK2α/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed Patients. , 2016, The American journal of pathology.
[7] Lifeng Gong,et al. Nox1 promotes colon cancer cell metastasis via activation of the ADAM17 pathway. , 2016, European review for medical and pharmacological sciences.
[8] Li Ding,et al. The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis , 2016, Oncogene.
[9] D. Largaespada,et al. Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation. , 2016, Cell reports.
[10] D. Orbach,et al. [Synovial sarcoma in children and adolescents]. , 2016, Bulletin du cancer.
[11] L. Pang,et al. Identification of potential mutations and genomic alterations in the epithelial and spindle cell components of biphasic synovial sarcomas using a human exome SNP chip , 2015, BMC Medical Genomics.
[12] C. Morrison,et al. Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib , 2015, Cold Spring Harbor molecular case studies.
[13] Rolph Pfundt,et al. Next generation sequencing in synovial sarcoma reveals novel gene mutations , 2015, Oncotarget.
[14] H. Jahr,et al. A transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17 and promotes lung epithelial tumor cell migration and lung metastasis formation , 2015, Cellular and Molecular Life Sciences.
[15] Hui Li,et al. A1 adenosine receptor–stimulated exocytosis in bladder umbrella cells requires phosphorylation of ADAM17 Ser-811 and EGF receptor transactivation , 2014, Molecular biology of the cell.
[16] S. Ferrari,et al. Emerging therapeutic targets for synovial sarcoma , 2014, Expert review of anticancer therapy.
[17] P. Dileo,et al. What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients , 2014, British Journal of Cancer.
[18] S. Lee,et al. Comparative Genomic Analysis of Primary and Synchronous Metastatic Colorectal Cancers , 2014, PloS one.
[19] Yujian Shi,et al. Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas , 2014, BMC Medical Genomics.
[20] S Gowrishankar,et al. ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines , 2013, British Journal of Cancer.
[21] P. Buckhaults,et al. Somatic Mutations, Allele Loss, and DNA Methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) Gene Reveals Association with Early Age of Diagnosis in Colorectal Cancer Patients , 2013, PloS one.
[22] Giovanni Parmigiani,et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma , 2012, Nature Genetics.
[23] Christine Unger,et al. In vitro cell migration and invasion assays. , 2013, Mutation research.
[24] A. Shinagare,et al. Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. , 2012, AJR. American journal of roentgenology.
[25] Jong-Wan Park,et al. Deficiency of H3K79 Histone Methyltransferase Dot1-like Protein (DOT1L) Inhibits Cell Proliferation* , 2011, The Journal of Biological Chemistry.
[26] L. Guillou,et al. Synovial sarcoma in patients under 20 years of age: a multicenter study with a minimum follow-up of 10 years , 2011, Journal of children's orthopaedics.
[27] Kenneth H. Buetow,et al. Bioinformatics Applications Note Sequence Analysis Bambino: a Variant Detector and Alignment Viewer for Next-generation Sequencing Data in the Sam/bam Format , 2022 .
[28] K. Siebenrock,et al. Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] P. Higgins,et al. In Vivo Selection of a Missense Mutation in adeR and Conversion of the Novel blaOXA-164 Gene into blaOXA-58 in Carbapenem-Resistant Acinetobacter baumannii Isolates from a Hospitalized Patient , 2010, Antimicrobial Agents and Chemotherapy.
[30] M. Stevens,et al. Synovial sarcoma in childhood and adolescence: A retrospective series of 77 patients registered by the Children's Cancer and Leukaemia Group between 1991 and 2006 , 2010, Pediatric blood & cancer.
[31] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[32] M. Gooz. ADAM-17: the enzyme that does it all , 2010, Critical reviews in biochemistry and molecular biology.
[33] R. Derynck,et al. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. , 2010, Molecular cell.
[34] B. Su,et al. SSeCKS/Gravin/AKAP12 Inhibits Cancer Cell Invasiveness and Chemotaxis by Suppressing a Protein Kinase C- Raf/MEK/ERK Pathway* , 2009, The Journal of Biological Chemistry.
[35] Samy Lamouille,et al. TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling. , 2009, Molecular cell.
[36] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[37] Tara L. Naylor,et al. Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues , 2009, Cancer biology & therapy.
[38] H. Paudel,et al. Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly-promoting Activity of Tau by Increasing Phosphorylation at Ser202 in Vitro* , 2009, Journal of Biological Chemistry.
[39] D. Edwards,et al. The ADAM metalloproteinases , 2008, Molecular Aspects of Medicine.
[40] J. Arribas,et al. Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17 , 2008, Biological chemistry.
[41] M. Capecchi,et al. Synovial Sarcoma: From Genetics to Genetic-based Animal Modeling , 2008, Clinical orthopaedics and related research.
[42] Randal L. Croshaw,et al. Somatic mutations to CSMD1 in colorectal adenocarcinomas , 2008, Cancer biology & therapy.
[43] P. Lander,et al. Synovial sarcoma: clinicopathologic features, treatment, and prognosis. , 2007, Orthopedics.
[44] M. Menger,et al. Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. , 2007, Neoplasia.
[45] Y. Okada,et al. ADAMs in cancer cell proliferation and progression , 2007, Cancer science.
[46] Malay Haldar,et al. A conditional mouse model of synovial sarcoma: insights into a myogenic origin. , 2007, Cancer cell.
[47] S. Soond,et al. ERK-mediated phosphorylation of Thr735 in TNFα-converting enzyme and its potential role in TACE protein trafficking , 2005, Journal of Cell Science.
[48] C. Blobel,et al. ADAMs: key components in EGFR signalling and development , 2005, Nature Reviews Molecular Cell Biology.
[49] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[50] G. Weskamp,et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.
[51] Kenji Shimizu,et al. Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1. , 2004, Cancer letters.
[52] R. Derynck,et al. Characterization of Growth Factor-induced Serine Phosphorylation of Tumor Necrosis Factor-α Converting Enzyme and of an Alternatively Translated Polypeptide* , 2003, The Journal of Biological Chemistry.
[53] M. Munsell,et al. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] R. Mariani-Costantini,et al. A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling. , 2003, The Journal of clinical endocrinology and metabolism.
[55] D. Seals,et al. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. , 2003, Genes & development.
[56] E. Dı́az-Rodrı́guez,et al. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. , 2002, Molecular biology of the cell.
[57] H. Sonobe,et al. Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2α , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[58] C. Blobel,et al. Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta. , 1999, The Biochemical journal.
[59] J. Lopes,et al. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins. , 1997, Human molecular genetics.
[60] H. Ohguro. High levels of rhodopsin phosphorylation in missense mutations of C‐terminal region of rhodopsin , 1997, FEBS letters.
[61] B. Castner,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. , 1997, Nature.